AusPAR: Ravulizumab
Australian Public Assessment Report
Device/Product Name
Ultomiris
Active ingredients
Ravulizumab
AusPAR Date
Published
Submission Number
PM-2018-05023-1-6
Submission Type
New chemical entity
Decision
Approved